Abstract
The activity of the β-glucuronidase inhibitor(BGI) previously described in whole human saliva was measured in individual saliva samples. BGI-activity was related to the ABO blood group and secretor status. No apparent relation was detected between DMF scores and either BGI activity, or secretor status. However, in non-secretors, a significant positive correlation was observed between DMF scores and BGI-activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
